Johnson & Johnson to Test Ebola Vaccine in January

The video discusses Johnson & Johnson's plan to produce an Ebola vaccine for trials, the company's strong financial performance, and increased production of the 737 jet. It also covers Daimler's sale of its Tesla stake, highlighting the evolving relationship between the two companies as Tesla becomes a competitor in the luxury car market.

What is Johnson & Johnson planning to do with their experimental Ebola vaccine?

• Use it for internal research only

• Distribute it to hospitals worldwide

• Test it on healthy volunteers

• Sell it to other pharmaceutical companies

What financial achievement did Johnson & Johnson report in the third quarter?

• A decrease in revenue

• Earnings and revenue below analyst estimates

• Earnings and revenue that exceeded analyst estimates

• A loss in their profit forecast

Why is Johnson & Johnson increasing production of its 737 jet?

• To reduce production costs

• To enter a new market

• Due to higher demand around the world

• To replace older models

How much did Daimler earn from selling its stake in Tesla?

• $1.5 billion

• $500 million

• $780 million

• $1 billion

What is the reason Daimler gave for selling its shares in Tesla?

• Tesla's shift to a different industry

• A need for immediate cash flow

• A lack of necessity for partnership and cooperation

• Tesla's declining market value